Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant …
P Kopschina Feltes, J Doorduin… - Journal of …, 2017 - journals.sagepub.com
Major depressive disorder (MDD) is a prevalent and disabling psychiatric disease with rates
of non-responsiveness to antidepressants ranging from 30–50%. Historically, the …
of non-responsiveness to antidepressants ranging from 30–50%. Historically, the …
Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant …
J Doorduin, HC Klein, LE Juárez-Orozco… - Journal of …, 2017 - europepmc.org
Major depressive disorder (MDD) is a prevalent and disabling psychiatric disease with rates
of non-responsiveness to antidepressants ranging from 30–50%. Historically, the …
of non-responsiveness to antidepressants ranging from 30–50%. Historically, the …
[PDF][PDF] Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune pro-file and non-responders to standard …
PK Feltes, J Doorduin, HC Klein… - THE TWO SIDES OF …, 2018 - meriva.pucrs.br
Abstract Major Depressive Disorder (MDD) is a highly prevalent and disabling psychiatric
disease with rates of non-responsiveness to antidepressants ranging from 30-50 …
disease with rates of non-responsiveness to antidepressants ranging from 30-50 …
[PDF][PDF] Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune pro-file and non-responders to standard …
PK Feltes, J Doorduin, HC Klein… - THE TWO SIDES OF …, 2018 - repositorio.pucrs.br
Abstract Major Depressive Disorder (MDD) is a highly prevalent and disabling psychiatric
disease with rates of non-responsiveness to antidepressants ranging from 30-50 …
disease with rates of non-responsiveness to antidepressants ranging from 30-50 …
Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant …
PK Feltes, J Doorduin, HC Klein… - Journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
Major depressive disorder (MDD) is a prevalent and disabling psychiatric disease with rates
of non-responsiveness to antidepressants ranging from 30-50%. Historically, the …
of non-responsiveness to antidepressants ranging from 30-50%. Historically, the …
[PDF][PDF] Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard …
PK Feltes, J Doorduin, HC Klein… - Journal of …, 2017 - researchgate.net
Major depressive disorder (MDD) is a prevalent and disabling psychiatric disease with rates
of non-responsiveness to antidepressants ranging from 30–50%. Historically, the …
of non-responsiveness to antidepressants ranging from 30–50%. Historically, the …
[HTML][HTML] Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard …
PK Feltes, J Doorduin, HC Klein… - Journal of …, 2017 - ncbi.nlm.nih.gov
Major depressive disorder (MDD) is a prevalent and disabling psychiatric disease with rates
of non-responsiveness to antidepressants ranging from 30–50%. Historically, the …
of non-responsiveness to antidepressants ranging from 30–50%. Historically, the …
[PDF][PDF] Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard …
PK Feltes, J Doorduin, HC Klein… - Journal of …, 2017 - core.ac.uk
Major depressive disorder (MDD) is a prevalent and disabling psychiatric disease with rates
of non-responsiveness to antidepressants ranging from 30–50%. Historically, the …
of non-responsiveness to antidepressants ranging from 30–50%. Historically, the …
Anti-inflammatory treatment for major depressive disorder: Implications for patients with an elevated immune profile and non-responders to standard antidepressant …
P Kopschina Feltes, J Doorduin, HC Klein… - Journal of …, 2017 - psycnet.apa.org
Major depressive disorder (MDD) is a prevalent and disabling psychiatric disease with rates
of non-responsiveness to antidepressants ranging from 30–50%. Historically, the …
of non-responsiveness to antidepressants ranging from 30–50%. Historically, the …
[PDF][PDF] Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune pro-file and non-responders to standard …
PK Feltes, J Doorduin, HC Klein… - THE TWO SIDES OF …, 2018 - tede2.pucrs.br
Abstract Major Depressive Disorder (MDD) is a highly prevalent and disabling psychiatric
disease with rates of non-responsiveness to antidepressants ranging from 30-50 …
disease with rates of non-responsiveness to antidepressants ranging from 30-50 …